Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges OPAD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares LGL Q1 2026 Earnings Loss Per Share Disappoints Amid Missing Revenue Data WRB Q1 2026 Earnings Strong Underwriting and Investment Performance Drive 124 EPS Beat Frontline Plc FRO Q4 2025 Earnings EPS Miss Weighs on Shares as Tanker Market Softens CPNG Q1 2026 Earnings EPS Misses by Over 200 Amid Strategic Investments Shares Rise 277